ABBREVIATIONS CI 95% =95% confidence interval; ORs=odds-ratios RUNNING HEAD Breastfeeding and asthma: systematic review P a g e | 3 ABSTRACT Asthma and wheezing disorders are common chronic health problems in childhood.
studies assessing asthma in children aged 5 or older, did not perform a meta-regression, and identified relatively few studies.
In this study, we aimed to identify and summarize all publications on breastfeeding and risk of asthma in unselected children, and use stratified analyses and meta-regressions to explore potential sources of heterogeneity.
MATERIAL AND METHODS
We complied with the requirements for reporting meta-analyses of observational studies (24, 25).
Search and selection
We searched PubMed and Embase with the following query: [breastfeeding OR breastfeeding OR "breast feeding" OR "breast fed" OR weaning] AND [asthma OR wheeze OR wheezing OR bronchiolitis OR bronchitis]. We looked for the terms in title and abstract and used MeSH terms for breastfeeding. We also included titles listed by other systematic reviews on breastfeeding and asthma. This report reflects the state of the literature as of July 31 st 2012.
Two authors (CD and DN) independently selected eligible studies in two stages: 1) scanning titles and abstracts; and (2) reading full-text. We obtained full texts from electronic databases, inter-library loans, or by contacting the authors. At the end of each stage, the reviewers compared their decisions and discussed discrepancies.
We included fully reported original studies, both cohort (longitudinal) and non-cohort studies (cross-sectional or case-control), and excluded duplicate reports, studies in the form of conference proceedings and abstracts, and studies not published in English. We considered studies performed in the general population, excluding studies performed in special populations, such as studies including only children with a family history of atopy or asthma (children "at risk"), or only children with diagnosed asthma/wheeze that analysed only the association between breastfeeding and asthma severity. We included studies that analysed, as outcomes, any of the following, alone or in combination: asthma diagnosis from medical reports; parental reports of current wheezing (≥1 episode in the past 12 months), treatment for asthma or wheezing; doctor diagnosis of asthma and wheezing with bronchial hyperresponsiveness. We excluded studies that did not differentiate between asthma/wheezing conditions and other respiratory or atopic conditions (e.g., "history of wheezing or bronchitis", "history of asthma or other allergies"), and also excluded studies that analysed only "wheeze ever" as an outcome.
Extraction of study characteristics
We extracted extensive information on breastfeeding, outcomes and study estimates (see below). In addition, we extracted author names and year of publication, date and country where the study was performed, study design, inclusion and exclusion criteria, length of follow-up, sample size, potential confounders adjusted for, type of analysis and author conclusion. We considered "Western" the countries from Europe, Australia/New Zealand or North and South America.
Breastfeeding, outcomes and study estimates. We separately extracted information on duration of any breastfeeding and duration of exclusive breastfeeding, when available. We recorded the age at which breastfeeding was assessed and the breastfeeding categories used by each study. For outcomes we recorded the definition used by each study, age of assessment and the source (parents, medical records, physicians). Whenever available, we extracted reported outcome prevalence within levels of breastfeeding and unadjusted and adjusted odds ratios.
Standardization of data extracted
After extraction, we reclassified the data on breastfeeding and outcomes into categories that would facilitate a more homogenous analysis. 0 to 3 months + 4 to 6 months). We then calculated unadjusted odds-ratios for each new categorization, using the category of shorter duration as reference; for the example presented above we thus calculated 3 odds-ratios. Whenever available, we also recorded the reported adjusted odds-ratios and unadjusted odds-ratios for studies that did not report prevalence, using the value of the most appropriate category.
The combination of 3 outcomes, 3 age groups, 2 breastfeeding types and 3 breastfeeding categories resulted in 45 separate groups within which we could perform meta-analyses of comparable studies, after excluding the categories "ever vs. never" for exclusive breastfeeding, which were not considered. A study could appear only once within the same group, but could belong to more than one group if we could recalculate more than one breastfeeding categorization, if it reported results for more than one outcome, breastfeeding type and/or age group.
Breastfeeding flexible categorization. To increase the number of studies that we could compare for a given outcome, we calculated ORs using a less stringent categorization (more vs. less breastfeeding) to compare studies regardless how they defined and categorized breastfeeding, and regardless of age of assessment. For this we started with the stringent categorizations described above and gave priority to the highest cut-off. Thus, in the example presented above, which reported outcome prevalence using breastfeeding categories never, 0 to 3 months, 4 to 6 months and >6 months, we recorded a breastfeeding more vs. less category taking the values from the ≥ 6 months vs.< 6 months categorization. When studies reported results for both "any breastfeeding" and "exclusive breastfeeding," we gave priority to results for exclusive breastfeeding. When studies reported results from more than one age group, we gave priority to results from school-age.
Quality assessment
To measure the methodological quality of studies, we defined a quality score based on (a) whether a study reported adjustment for at least three of seven important potential confounders (17, 18) and (b) whether it satisfied at least four of seven of the selected quality standards suggested by Kramer (17) . We assigned one point for each of these criteria, resulting in a score that ranged from 0 to 2. For reporting purposes, we labelled them 0=low, severity of outcome, age of onset of outcome, adequate statistical power) were difficult to assess in the selected studies and therefore were not included in the score.
Statistical analysis
We performed separate meta-analyses for each outcome, first within the 45 groups defined by breastfeeding cut-offs and then using the more vs. less breastfeeding categorization.
The odds-ratios included in analyses were either provided by the studies or calculated from the reported frequencies. We used a random-effects model with the DerSimonian and Laird method to calculate weights (26). If studies reported both adjusted and unadjusted odds-ratio, we used the adjusted estimates.
In the analyses using more vs. less breastfeeding we addressed heterogeneity between studies by performing meta-analyses stratified by age, study design, Western country, recent study (conducted before/after 1990) and quality score. We also fitted meta-regressions, using as determinants age, study design, Western country, recent study, quality score, type of breastfeeding and breastfeeding categorization used. The analysis for recent wheezing illness also included type of recent wheezing illness (asthma vs. wheeze). Analyses were done in Stata 12.0 (Stata Corporation, Austin, Texas) and used the metan and metareg commands (27).
RESULTS

Study characteristics
Search. Figure I presents the search and selection process. Our search yielded 1464 titles.
Eighteen articles, not traced by our search, were identified from other systematic reviews on the same topic. After some of the duplicate titles were automatically excluded by the managing program (EndNote), we screened 1083 titles, of which 217 were retained. We dropped nine studies because the author was suspected of data fabrication, and the articles had been retracted by journals (28). After reading full-texts, we retained 108 titles (12, .
Of these, 3 were multi-country studies that reported results grouped by geographical region or affluence. We included the results of these group analyses as separate studies (n=12). We thus included 117 studies in our review. Four of them used breastfeeding as a continuous variable and were excluded from meta-analyses. 
Characteristics. Tables 2 and Web
Meta-analysis and meta-regression
Breastfeeding stringent categorization. Table 2 show in detail the results of the meta-analyses performed in the 45 groups for each the three outcomes, and Web Table 3 for the 94 studies reporting recent wheezing illness.
When we stratified by age at outcome, we found evidence of a reduced risk with longer breastfeeding for all outcomes at 0-2 years, 3-6 years and ≥7 years of age, respectively, with a consistent decreasing trend in the extent of risk reduction with older age. Meta-analyses for asthma ever and recent asthma from cohort studies, studies performed in Western countries and studies performed before 1990 showed pooled ORs that tended to be closer to 1 ( no association) compared with studies performed in non-cohorts, in non-Western countries and after 1990, respectively. In all analyses we found high levels of heterogeneity, except for the analyses on asthma ever and recent asthma in studies analysing the outcome in children 0-2 years and in studies classified as high quality (Web Table 4 ).
Meta-regressions.
We present the results from the meta-regressions in Table 3 . For asthma ever the pooled OR of studies performed in children ≥7 years of age was 1.26 times higher (CI 95% =0.97,1.6; P=0.08) than the pooled OR of studies assessing outcomes in children 0-2 years old, indicating that the reduction in risk of asthma in breastfed children is smaller in children ≥7 years of age than in children 0-2 years old (the pooled OR is closer to 1, noassociation lower quality, performed in Western or non-Western countries, or between those that used different breastfeeding definitions and categorizations.
DISCUSSION
We found evidence that children who are breastfed longer have a lower risk of developing asthma. Risk reduction is most pronounced in children 0-2 years old and decreases with age, but is still evident at school age. Studies were highly heterogeneous, but our results were similar when we included only longitudinal cohort studies, or limited the selection to studies of high methodological quality.
Compared with other reports, our review included a larger number of studies. We minimally restricted search and study selection, including studies of different methodologies, different operationalizations for breastfeeding and asthma, and different sets of confounders, which may have increased the variability of effect estimates. We tried to account for this by performing meta-analyses in standardized subgroups and by performing meta-regressions with a broad array of predictors. We included an assessment of the methodological quality of the studies, using criteria based on Kramer's standards (17) and recent recommendations (18) and included the quality score in the analyses that addressed the heterogeneity we found among studies.
Quality of included studies
All included studies were observational and therefore prone to bias. We quantified the methodological quality of each study with a quality score based on adjustment for essential confounders and the standards proposed by Kramer in 1988(17) . Based on our quality score, the overall quality of the studies was low, especially due to insufficient adjustment for confounders; this may explain why the studies categorized by our criteria as of low and high quality did not differ much. Studies with a higher quality score were less heterogeneous, which suggests that higher quality standards increase consistency of results, probably by reducing bias.
Interpretation of findings
Our study strongly suggests that breastfeeding is protective against the development of childhood asthma. We found the strongest association in children 0-2 years old; the strength of association decreases with age. This is consistent with the hypothesis that wheezing conditions in infants are likely to be triggered by viral respiratory infections, against which breastfeeding is an established protector (136) (137) (138) . As the child develops, more and more factors influence respiratory morbidity, making it difficult to discern the specific influence of breastfeeding. We do still find some evidence of risk reduction at school age. There is a hypothesis that development of later asthma is mediated by respiratory infections in early life; analysis by dividing it into Western and non-Western countries. One ISAAC study found that breastfeeding was associated with a decreased risk of wheezing in both affluent and nonaffluent countries, but in non-affluent countries this was true only for non-atopic wheeze (145) . Our meta-analysis did not find different levels of protection offered by breastfeeding in Western vs. non-Western countries. However, studies from non-Western countries were more heterogeneous, perhaps due to poorer methodological aspects of the studies, as suggested by the fact that 17% of studies performed in Western countries had a quality score of 2 (high quality), while only 4% of non-Western countries received this score.
Possible limitations
We excluded from our search studies reported as conference proceedings and abstracts, because we intended to extract as much information as possible, expecting the studies to be observational and therefore heterogeneous. We considered that studies published as conference proceedings or abstracts might lack the depth of information needed. We excluded non-English papers, due to lack of translators. It is possible that exclusion of conference proceedings/abstracts has introduced publication bias. Excluding studies reported in other languages than English may have introduced a bias in favour of "positive results" (147, 148).
To check a possible impact of excluding non-English studies, we analysed the 12 eligible studies, which had their abstracts in English. Unfortunately the information contained in the abstracts was limited; therefore we could not perform a systematic analysis. Half of them (6) analysed the outcome at >7 years, 1 study at 5 years, 4 studies at age 0 to 2 years, and 1 at mixed ages (0 to 14 years). Nine studies reported "protective association" and 3 studies reported "no association." The studies reporting "no association" were performed at > 7 years or mixed ages. While this is not a systematic analysis, we think that it shows a similar pattern with our main findings and therefore their exclusion did not alter the main results and their interpretation P a g e | 19
Conclusion and recommendations
Our review brought to light the wide heterogeneity of studies that consider the role of breastfeeding in the development of asthma and some of the common methodological problems.
We make the following recommendations for future studies.
Study design. Studies should use a longitudinal design, recruit women during pregnancy and assess duration of breastfeeding and incidence of asthma symptoms prospectively. A study design based on sibling comparisons could allow for a better control for genetic and environmental factors, which are partially shared [149] . Taylor B, Wadsworth J, Golding J, et al. Breast feeding, eczema, asthma, and hayfever. d Asthma ever: lifelong reports of asthma diagnosis (from parent reports or medical records) and/or use of asthma/wheeze treatment and/or wheeze accompanied by bronchial hyper-reactivity; from those, the ones that reported the condition in the past 12 months were analysed separately as recent asthma. Recent wheezing illness combines recent asthma and recent wheezing (single or multiple episodes in the past 12 months). The meta-regression coefficients are to be interpreted as "ratio of odds ratios", i.e., the relative change in the pooled ORs when the explanatory variable (study characteristic) is different by one unit, holding everything else constant. For example, the 1.257 coefficient for school age in the meta-regression for asthma ever means that the studies performed at school age yield a pooled OR 25.7% larger than studies performed in children 0-2 years old. In this case it means that the protective effect of breastfeeding in children ≥7 years of age is lower than the one in children 0-2 years old (the larger OR is closer to 1, the non-effect).
Measurement
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c Country from Europe, North-and South-America or Australia/New Zealand d Age when the outcome was assessed e Whether the analysis used duration of any breastfeeding or duration of exclusive breastfeeding f The breastfeeding stringent categorization used in analysis (ever vs. never; ≥ 3-4 months vs. <3-4 months; or ≥6 months vs. <6 months) g Quality score: one point is assigned for adjusting for ≥3 essential confounders (birth weight, gestational age, ethnicity, family history of asthma or allergy, family education, socio-economic status and exposure to tobacco smoke pre and postpartum) and one point for meeting >3 Kramer quality criteria (non-reliance on prolonged breastfeeding recall; sufficient duration of breastfeeding; sufficient exclusivity of breastfeeding; strict diagnostic criteria; adjustment for essential confounders; assessment of dose-effect; assessment of children with family history of atopy) FIGURES LEGENDS Note. The graph presents pooled odds ratios with confidence intervals for the meta-analyses performed in each of the stringent breastfeeding categorization groups, separated by age and type of breastfeeding. For reasons of symmetry, the graph is presented on a log-scale. Abbreviations: No. = number of studies meta-analysed in each group; OR=odds ratio; CI=confidence intervals (95%) The graph presents pooled odds ratios with confidence intervals for the meta-analyses performed in each of the stringent breastfeeding categorization groups, separated by age and type of breastfeeding. For reasons of symmetry, the graph is presented on a log-scale. Abbreviations: No. = number of studies meta-analysed in each group; OR=odds ratio; CI=confidence intervals (95%) Figure 4 . ASTHMA EVER: pooled odds-ratios of meta-analyses performed by "more vs. less breastfeeding" in all studies and stratified by age, design, country and quality score
The graph presents pooled odds-ratios and 95% confidence intervals from the random-effects meta-analyses performed in the entire group and stratified by age, study design, country type and study quality. For reasons of symmetry, the graph is presented on a log-scale. Abbreviations: No. = number of studies meta-analysed in each group; OR=odds ratio; CI=confidence intervals (95%) Figure 5 . RECENT ASTHMA: pooled odds-ratios of meta-analyses performed by "more vs. less breastfeeding" in all studies and stratified by age, design, country and quality score
The graph presents pooled odds-ratios and 95% confidence intervals from the random-effects meta-analyses performed in the entire group and stratified by age, study design, country type and study quality. For reasons of symmetry, the graph is presented on a log-scale. Abbreviations: No. = number of studies meta-analysed in each group; OR=odds ratio; CI=confidence intervals (95%)
